


Dedicated physicians & scientists determined to improve outcomes in patients with gastrointestinal cancers through basic and translational research @DanaFarber


The genomic afterlife of cancer therapy: doi.org/10.1172/JCI213544 In this Viewpoint, Xiaolu Wang and Nilay S. Sethi @danafarber consider the biological consequences of treatment for long-term cancer survivors. @the_asci

Please share thoughts and feedback on our commentary in @jclinicalinvest . Cancer survivorship genomics is an emerging field with plenty of potential to shape clinical care. How should we interpret mutational signatures in cancer survivors? @MattYurgelun
The genomic afterlife of cancer therapy: doi.org/10.1172/JCI213544 In this Viewpoint, Xiaolu Wang and Nilay S. Sethi @danafarber consider the biological consequences of treatment for long-term cancer survivors. @the_asci

This is a comprehensive and thorough review. Anyone who wants to jump into the colorectal cancer field, this is a great place to start. Well done @owen_sansom and Simon Leedham
NEW content online! Origins and heterogeneity of colorectal cancer dlvr.it/TWDPXT

Research at #ESMO26, presented by @VincentWenxinXu of @DanaFarber, shows among patients with advanced #kidneycancer on immunotherapy alone, KIM-1 reductions were seen in immune-inflamed tumors, while no KIM-1 drop was linked to immune-depleted tumors. CC: @DanaFarber_GU

How are advances in treatment, prevention, and surgical care changing the management of polyposis syndromes? At #CGAIGC26, Dr. Leah Biller, Dr. Jeongyoon Moon, and Dr. Ajay Bansal will explore evolving approaches to polyposis care, from therapy-associated polyposis and functional outcomes following colorectal surgery to the latest evidence in chemoprevention. 🔗 Learn more about our speakers and their presentations: Dr. Leah Biller: bit.ly/4i9BUkH Dr. Jeongyoon Moon: bit.ly/48mF3Yx Dr. Ajay Bansal: bit.ly/4iiaJ6d 📅 November 4 | 10:45 AM – 12:15 PM

Congratulations to @MuzumdarLab and @SStevenWang, recipients of an @theNCI #R33 award, which they will use to develop #RAEFISH, an innovative spatial transcriptomics technology. medicine.yale.edu/cancer/new… @SmilowCancer @YaleGenetics

It is so exciting to build the understanding of the function differences between EP300 and CBP, which can be applied to target specific therapy development.
This was a major effort between the @Adurbinlab @TheAbraLab @JunQiLab and the Ory labs. We pick up on a long-term interest of our labs: the attractive target, EP300. EP300 is a great cancer target because while many tumor cells require it, they often may not need its paralog CBP

Interested in studying the origins of lung cancer and regulation of development, cell fate, metabolism in human lung progenitors? All in a rigorous, science-loving, supportive environment? I'm looking for postdoctoral fellows, students, technicians! DM me. Please retweet!

A New Era for Colorectal Cancer Care at MD Anderson - Scott Kopetz @skopetz oncodaily.com/industry/scott…

Beautiful study by the @Oser_Lab! Crispr screen applied to custom reporter revealed HUWE1 is a stability regulator or ASCL1, lineage TF driving a major subtype of SCLC. Then base editor screens identify functional domains, including an uncharacterized IDR. Elegant and rigorous!
Excited to share another new study from our lab, co-led by Keita Masuzawa and Kevin Dong: “A HUWE1 Regulatory Helix Gates ASCL1 Degradation Through Its C-Terminal Phospho-Degron in Small Cell Lung Cancer.” genesdev.cshlp.org/content/e…

We appreciate the support from @DanaFarber and are grateful to the patients who participated.
A new study in @jclinicalinvest led by @danafarber’s @labsethi sheds light on therapy-associated polyposis, a rare condition that can develop decades after cancer treatment in childhood or young adulthood. For the first time, researchers identified lasting molecular evidence of genetic damage linked to chemotherapy in precancerous colorectal growths. Read more here: bit.ly/4hIrB70

Great collaboration with @SwagataGoswam16, @ohyilmaz , and colleagues

Increased dietary fats leads to more aggressive colorectal cancer via ceramide synthesis and YAP regenerative signaling. A metabolic memory of the exposure persists. science.org/eprint/UAMCP9BAE…

Great collaboration with @ohyilmaz, @SwagataGoswam16, and colleagues!

Grateful to the patients, collaborators, and team who made this study possible. @MattYurgelun #ChildhoodCancer #CancerSurvivorship #ColorectalCancer #polyposis